This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Just as the holiday season begins, a sleighful of companies unveiled large funding rounds. xAI , $5B, artificialintelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. The $6 billion round valued the company at $24 billion post money.
The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. EvolutionaryScale , $142M, biotech: It was a big week for biotech. billion, per Crunchbase.
This week’s theme was definitely AI, as many of the largest rounds went to startups using AI in coding or biotech. Xaira Therapeutics , $1B, biotech: The biggest round this week was really big. Xaira is the latest — although likely best-funded — startup to try to use AI models to find new drugs. billion in March 2023.
Gen Teare Health and biotech Hinge Health : This is another IPO prediction where were not exactly going out on a limb (pun intended in this case). The San Francisco-based company offers virtual physical therapy services and was last valued at $6.2 billion in a $600 million Series E in 2021 led by Tiger Global and Coatue.
Terray Therapeutics , $120M, biotech: Los Angeles-based Terray Therapeutics, a biotech startup developing small molecule drug therapeutics, raised a $120 million Series B led by new investor Bedford Ridge Capital and existing investor NVentures. Founded in 2021, the company has raised nearly $318 million, per Crunchbase.
AlphaSense , $650M, artificialintelligence: AI-driven market intelligence platform AlphaSense raised $650 million in funding co-led by Viking Global Investors and BDT & MSD Partners at a $4 billion valuation — a 75% increase from just nine months ago. Founded in 2011, the company has raised $1.4 billion, per Crunchbase.
One is putting in secure chat, so developers can converse freely with the LLM about their specific coding issues, as opposed to just going to OpenAI where there isn’t necessarily sufficient trust to share issues about proprietary code. Some will probably sell a service where they adapt open models to specific problems.”
But when an idea originates in a lab — whether it’s AI, biotech, robotics or another deep tech research project — things quickly become tougher and much more expensive. Letting the AI do your crafting : Writer deploys home-cooked largelanguagemodels to power up enterprise copy , Devin reports. billion , up from the $1.3
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. Augment , $227M, artificialintelligence: AI coding startups are making a big splash. Let’s take a look.
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space.
When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligentvirtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.
With all the venture funding in biotech , it is no surprise that one of the largest deals was Merck ’s acquisition of New York-based eye disease therapy company Eyebiotech. And had artificialintelligence startups Inflection AI , Character.ai
Angel AI says it uses largelanguagemodels, natural language processing, speech recognition and other tech to generate age-appropriate answers to children’s questions and deliver what the company calls compelling but safe content and entertainment. The Menlo Park, California-based biotech firm locked up a $5.5
Kore.ai , $150M, artificialintelligence: Of course there’s a big round for a generative AI startup. The startup is not new to the AI scene — it’s a decade old — and offers an array of artificialintelligence-related tech from virtual assistants to no-code tools to build AI apps. billion in October 2022.
Last month, a16z seemed to have a thing for healthcare and biotech. The startup uses artificialintelligence to extract “the full image quality potential” from smartphone cameras by reversing “lens aberrations and sensor imperfections.” based startups. million seed round for Los Altos, California-based Glass Imaging.
Once the port is implanted in the chest and the catheter goes through a patient’s heart, the device captures images of blood cells and then compresses the data and sends it to the cloud, after which it is analyzed via machinelearning.
AI-enabled healthcare There’s a lot of funding for nascent companies at the intersection of artificialintelligence and healthcare. New York-based Jona wants to use artificialintelligence to uncover links between the microbiome and health. Without further ado, here are five of our top trends for seed-stage.
The city appears to be strong in areas such as travel, AI, cybersecurity, fintech, agritech, travel tech, biotech, sports tech, and VR. The city’s investment scene is not particularly large and most investors focus on seed funding, but it’s growing as family-owned companies, and individual and institutional investors turn to tech.
Its also possible the distinction of being an AI startup will fade over time, as virtually every company adopts the technology. While the most heavily funded generative AI players are in the San Francisco area, the regions dominance is less pronounced for startups working on industry-specific AI applications.
Michael Antonov caught “the longevity bug” after helping to found Oculus Rift, the virtual reality headgear company, and selling it to Facebook for $2.3bn. In June 2012, Antonov and his business partner joined forces with Palmer Lucky to found Oculus, a California-based company making headsets for virtual reality software.
machinelearning , allowing for analyzing the knowledge contained in the source data and generating new knowledge. virtually — when the data remains in its original formats, but the knowledge graph integrates the original datasets at the level of abstract schemas (see our article about data fabrics). Here are the key ones.
Pharma/Biotech: $3,295. At ATA2020, you will become immersed in the novel application of virtual care technologies, deepen your understanding of patient and consumer perspectives and motivations, and bring clarity to the challenges, policies and opportunities to implementing telehealth solutions in value-based delivery models.
Drug Patent Image Annotation for a South Korean Biotech Research Company Our client needed bounding box annotation for a set of drug patent images. Adoption of AI ArtificialIntelligence is revolutionizing the industry, enabling the automation of repetitive tasks, enhancing efficiency, and reducing costs.
Kore.ai , $150M, artificialintelligence: Another week and another big round for a generative AI startup. The startup is not new to the AI scene — it’s a decade old — and offers an array of artificialintelligence-related tech from virtual assistants to no-code tools to build AI apps. billion, per Crunchbase.
InstaDeep utilizes advanced machinelearning techniques, including deep reinforcement learning in applications within an enterprise environment that cuts across various industries such as biotech, transportation, electronics manufacturing and logistics. That was crazy.
Fisher, Smith and Walsh sought to create a service that could process historical clinical trial data sets from patients to build “disease-specific” machinelearningmodels, which could in turn be used to create digital twins with corresponding virtual medical records.
They create virtual warehouses to store it, invisible infrastructures to support its travels, apply algorithms to help it transform into something tangible. This was proven by Moderna, an American biotech company, that announced the development of the first candidate for COVID-19 vaccine back in February 2020.
Medical technology or MedTech may include medical devices, information technology, biotech, and healthcare services. Artificialintelligence involves the ability for machines to learn, adapt, and evolve from experience much in the same way that a human can. Virtual Reality. AI Technology.
Some people are more excited by emerging areas like artificialintelligence, which has been a focus of the country’s military for years, and like cybersecurity is now producing many fresh teams of founders. A great amount of talent is cultivated in the military, which has spawned innovative cyber, AI and machine-learning companies.
It uses machinelearning and bioinformatics to analyse and predict vaginal microbiomes’ impact on female fertility. The company has raised $26m from a number of biotech investors. Apricity This startup offers virtual fertility clinic services and assistance by expert advisers on pregnancy issues through its app.
Anthropic , $1B, artificialintelligence: Anthropic, a ChatGPT rival with its AI assistant Claude, is reportedly taking in a fresh $1 billion investment from previous investor Google. Rhino.ai , $50M, artificialintelligence: Washington, D.C.-based The goings on in Washington, D.C.,
This week defense and artificialintelligence led the way with massive rounds, but healthcare, security and more also saw big raises. Abridge , $250M, healthcare: Abridge, which uses artificialintelligence to build medical documents, became the latest healthcare/biotech that uses AI to raise big.
The rise of forward-deployed sales engineers Palantir Technologies exemplifies the future of sales with its forward-deployed software engineer, or FDSE, model technical experts embedded within customer operations to ease integration and optimize solutions in real time.
Its preferred sectors are ‘techbio’ (by which he means tech-focused biotech businesses), software (especially software as a service, or SAAS), energy and fintech. It likes to invest in platforms, and picks and shovels, which means businesses which can become part of the essential infrastructure for many larger companies.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content